November 7, 2017 | REAN Cloud
Cardiovascular disease is the #1 cause of death in the United States, and the world, killing more than 600,000 Americans and 17.5 million people worldwide each year, with a current global cost of $900 billion and expectations to exceed $1 trillion by 2030. The American Heart Association (AHA) is focused on improving the cardiovascular health of all Americans by 20%, and reducing death from the disease by the same measure, by 2020. While the AHA is a US-based organization, however, it has a global team that reaches into 80 countries and 7 regional offices. This means daily, hundreds of researchers around the world are collaborating to improve cardiovascular health and reducing death rates.
The AHA has long-since understood that the more accessible data is to researchers, the more useful it becomes and requires teams to share research for better transparency and collaboration. This hasn’t always been easy, but thanks to new innovations in cloud-based technology, AHA was able, with REAN Cloud’s help, to create a truly collaborative platform to enable next-generation information sharing, efficiently and securely, with teams around the world.
REAN Cloud’s deep expertise helping customers in highly regulated industries such as healthcare and life sciences made us a good fit to help the AHA in its goal of greatly improving patient outcomes using the power of the cloud to make it easier and faster for researchers to share their work by building the new AHA Precision Medicine Platform.
In a recent talk to the Imagine: A Better World conference, co-presented by AWS and Amazon, Nancy Brown, CEO of the AHA described the difference the new platform makes for researchers: “Without the power of cloud computing and without the power of this community we’ve built, we’re talking about the difference of five years [to gather data] and simple clicks in this Precision Medicine Platform.”
Steve Toback, Director, Engineering at REAN Cloud® and Pradyot Prasoon, leader for Business Strategies for Emerging Technologies and Strategic Partnerships at the AHA, will co-present a case study on the AHA’s Precision Medicine Platform at AWS re:Invent on November 27th in Las Vegas.
In this session, attendees will learn how we architected the AHA Precision Medicine Platform to facilitate healthcare research collaboration and data discovery for hundreds of scientists around the world while ensuring compliance with all relevant regulations.
The session will detail how the platform adheres to the strict security and logging requirements necessary for compliance with HIPAA and FedRAMP by using AWS Identity and Access Management, AWS CloudTrail, AWS Config and Amazon Kinesis, as well as how to catalog, discover and analyze precision medicine cohorts at scale using Amazon S3, Amazon EMR, Amazon Elasticsearch Service, and Amazon AppStream 2.0.
The platform is now available for other researchers to use as well. Researchers can use their NIH Commons Cloud Credits and begin using it on day one.
To learn more about AHA’s Precision Medicine Platform, you can also watch AHA CEO Nancy Brown’s presentation at the Imagine: A Better World conference on YouTube. For more information about using the platform yourself, please contact us at +1(844)377-7326 or use the online form.
And, if you are going to attend AWS re:Invent, please stop by booth #1839 for a 1-on-1 consultation.